Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 7Lymphoid 6Myeloid 3Genitourinary 3Tumor-Agnostic 2Plasma cell 2Other solid neoplasm 2Gynecologic 2CNS 2Breast 2Thoracic 1Sarcoma 1Head & Neck 1Dermatologic 1

Conditions

Neoplasms 2

Interventions

pembrolizumab 94Paclitaxel 85Gemcitabine 83Carboplatin 79Docetaxel 60Cisplatin 58Bevacizumab 58Nivolumab 56Fluorouracil 47Capecitabine 46Magnetic Resonance Spectroscopy 44Radiotherapy 41Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 37Pemetrexed 34Leucovorin 34Biopsy 34atezolizumab 33Cetuximab 32Standard of Care 31Trastuzumab 28Cyclophosphamide 28Radiosurgery 27Blood Specimen Collection 27Specimen Handling 26Sorafenib 26Ipilimumab 26Everolimus 26olaparib 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Fluconazole × Tumor-Agnostic × Clear all
NCT06071650 2023-10-06

Assessment, Monitoring and Optimisation of Prehabilitation Patients Using Wearable Fitness Trackers

Imperial College London

Phase NA Unknown
82 enrolled
Tumor-Agnostic

Neoplasms

NCT05661591 2023-04-04

Effect of Fluconazole on Pharmacokinetics of SHR2554 in Healthy Subjects

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Completed
18 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡